Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)

Published:1995-10 Issue:8 Volume:6 Page:833-835
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Pirker R.,Krajnik G.,Zöchbauer S.,Malayeri R.,Kneussl M.,Huber H.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/6/8/833/530905/6-8-833.pdf

Reference12 articles.

1. Polychemotherapy in advanced non-small-cell lung cancer A meta-analysis;Souquet;Lancet,1993

2. Chemotherapy for advanced non-small-cell lung cancer How much benefit is enough?;Grilli;J Clin Oncol,1993

3. Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer;Lilenbaum;J Clin Oncol,1993

4. Phase H study of Taxol, Merba-rone, and Piroxantrone in stage IV non-small-cell lung cancer;Chang;The Eastern Cooperative Oncology Group Results. J Natl Cancer Inst,1993

5. Phase II study of Taxol in patients with untreated advanced non-small-cell lung cancer;Murphy;J Natl Cancer Inst,1993

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of the combination of paclitaxel, cisplatin and bevacizumab for the treatment of non-small cell lung cancer;Tropical Journal of Pharmaceutical Research;2024-05-10

2. Tumor-associated macrophages in non-small-cell lung cancer: From treatment resistance mechanisms to therapeutic targets;Critical Reviews in Oncology/Hematology;2024-04

3. Recent Progress of Paclitaxel Delivery Systems: Covalent and Noncovalent Approaches;Advanced Therapeutics;2023-02-08

4. Recent Developments and Anticancer Therapeutics of Paclitaxel: An Update;Current Pharmaceutical Design;2022-11

5. Untargeted Lipidomics of Non-Small Cell Lung Carcinoma Demonstrates Differentially Abundant Lipid Classes in Cancer vs. Non-Cancer Tissue;Metabolites;2021-10-28